These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

568 related items for PubMed ID: 20546437

  • 21. HBeAg-negative chronic hepatitis B: why do I treat my patients with nucleos(t)ide analogues.
    Lampertico P, Colombo M.
    Liver Int; 2009 Jan; 29 Suppl 1():130-2. PubMed ID: 19207976
    [Abstract] [Full Text] [Related]

  • 22. Chronic hepatitis B with advanced fibrosis or cirrhosis: impact of antiviral therapy.
    Arora G, Keeffe EB.
    Rev Gastroenterol Disord; 2007 Jan; 7(2):63-73. PubMed ID: 17597674
    [Abstract] [Full Text] [Related]

  • 23. Viral genotype and baseline load predict the response to adefovir treatment in lamivudine-resistant chronic hepatitis B patients.
    Buti M, Elefsiniotis I, Jardi R, Vargas V, Rodriguez-Frias F, Schapper M, Bonovas S, Esteban R.
    J Hepatol; 2007 Sep; 47(3):366-72. PubMed ID: 17561304
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Adefovir dipivoxil treatment of lamivudine-resistant chronic hepatitis B.
    Dai CY, Chuang WL, Hsieh MY, Lee LP, Huang JF, Hou NJ, Lin ZY, Chen SC, Hsieh MY, Wang LY, Tsai JF, Chang WY, Yu ML.
    Antiviral Res; 2007 Aug; 75(2):146-51. PubMed ID: 17400303
    [Abstract] [Full Text] [Related]

  • 30. Monitoring of therapy in patients with chronic hepatitis B virus.
    Arrese E, Basaras M, Blanco S, Ruiz P, Cisterna R.
    Eur J Gastroenterol Hepatol; 2010 Jun; 22(6):736-40. PubMed ID: 19550344
    [Abstract] [Full Text] [Related]

  • 31. Susceptibility of hepatitis B virus to lamivudine restored by resistance to adefovir.
    Zaaijer HL, Takkenberg RB, Weegink CJ, Rebers SP, Menting S, Reesink HW, Schinkel J, Molenkamp R.
    J Med Virol; 2009 Mar; 81(3):413-6. PubMed ID: 19152408
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Viral response at 6 months is associated with treatment outcome of adefovir add-on therapy for lamivudine-resistance.
    Kim YJ, Paik SW, Sinn DH, Gwak GY, Choi MS, Lee JH, Koh KC, Yoo BC.
    J Gastroenterol Hepatol; 2012 Sep; 27(9):1454-60. PubMed ID: 22168753
    [Abstract] [Full Text] [Related]

  • 34. Clinical and virological effects during two years of ongoing adefovir dipivoxil in the treatment of lamivudine-resistant chronic hepatitis B infection.
    Gornals JB, Casanovas T, Sabidó M, Baliellas C, Casanovas A, Cañas C, Serrano T, Verdura B, Chahri N, Gil-Vernet S, Figueras J.
    Transplant Proc; 2005 Nov; 37(9):3957-9. PubMed ID: 16386595
    [Abstract] [Full Text] [Related]

  • 35. Considerations for the long-term treatment of chronic hepatitis B with nucleos(t)ide analogs.
    Petersen J, Buti M.
    Expert Rev Gastroenterol Hepatol; 2012 Dec; 6(6):683-93; quiz 694. PubMed ID: 23237254
    [Abstract] [Full Text] [Related]

  • 36. The rtA194T polymerase mutation impacts viral replication and susceptibility to tenofovir in hepatitis B e antigen-positive and hepatitis B e antigen-negative hepatitis B virus strains.
    Amini-Bavil-Olyaee S, Herbers U, Sheldon J, Luedde T, Trautwein C, Tacke F.
    Hepatology; 2009 Apr; 49(4):1158-65. PubMed ID: 19263474
    [Abstract] [Full Text] [Related]

  • 37. HBV DNA level at 24 weeks is the best predictor of virological response to adefovir add-on therapy in patients with lamivudine resistance.
    Shin JW, Jung SW, Park BR, Kim CJ, Eum JB, Kim BG, Du Jeong I, Bang SJ, Park NH.
    Antivir Ther; 2012 Apr; 17(2):387-94. PubMed ID: 22293395
    [Abstract] [Full Text] [Related]

  • 38. [The efficacy of adefovir dipivoxil monotherapy and the incidence of genotypic resistance to adefovir dipivoxil in patients with lamivudine-resistant chronic hepatitis B infection].
    Moon JH, Cho M, Yoon KT, Bae JH, Heo J, Kim GH, Kang DH, Song GA.
    Korean J Hepatol; 2008 Dec; 14(4):503-12. PubMed ID: 19119245
    [Abstract] [Full Text] [Related]

  • 39. Analogs and fibrosis regression in hepatitis B.
    Bourlière M, Kahloun A, Gascou-Tessonnier G.
    Gastroenterol Clin Biol; 2009 Dec; 33(10-11):923-9. PubMed ID: 19640665
    [Abstract] [Full Text] [Related]

  • 40. Review article: Success and failure of nucleoside and nucleotide analogues in chronic hepatitis B.
    Leemans WF, Ter Borg MJ, de Man RA.
    Aliment Pharmacol Ther; 2007 Dec; 26 Suppl 2():171-82. PubMed ID: 18081660
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 29.